Fundamental Valuation Report Acorda Therapeutics(ACOR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.74 (USD) 28/02/2019 Weighted Valuation$21.10 (USD) Overall RatingUndervalued by 43.2% Valuation Models Analyst Consensus: $23.67 (USD) (in …

Acorda Therapeutics (ACOR:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Aduro Biotech(ADRO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.30 (USD) 28/02/2019 Weighted Valuation$6.65 (USD) Overall RatingUndervalued by 54.7% Valuation Models Analyst Consensus: $8.00 (USD) (in …

Aduro Biotech (ADRO:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Ameriprise Financial(AMP:NYS) Financial Services:Asset Management This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$131.63 (USD) 28/02/2019 Weighted Valuation$128.07 (USD) Overall RatingFairly valued to slightly Overvalued by 2.7% Valuation …

Ameriprise Financial (AMP:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Amarin Corp(AMRN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$20.47 (USD) 28/02/2019 Weighted Valuation$37.42 (USD) Overall RatingUndervalued by 82.8% Valuation Models Analyst Consensus: $43.00 (USD) (in …

Amarin Corp (AMRN:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report American Tower(AMT:NYS) Communication Services:Telecom Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$176.15 (USD) 28/02/2019 Weighted Valuation$167.46 (USD) Overall RatingFairly valued to slightly Overvalued by 4.9% Valuation …

American Tower (AMT:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Altaba(AABA:NAS) Financial Services:Asset Management This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$74.59 (USD) 28/02/2019 Weighted Valuation$70.83 (USD) Overall RatingOvervalued by 5.0% Valuation Models Analyst Consensus: $76.00 (USD) …

Altaba (AABA:NAS) Fundamental Valuation Report Read more »

Read More